Monthly MS Drug Wins in Trial

(MedPage Today) -- A pegylated form of interferon-beta-1a for multiple sclerosis that may enable monthly dosing was effective in reducing relapse rates in a placebo-controlled trial, the drug's manufacturer said.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news